Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
G48PAbmgnQqBncsG